• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Relative potencies for barbiturate binding to the Torpedo acetylcholine receptor.巴比妥酸盐与电鳐乙酰胆碱受体结合的相对效价。
Br J Pharmacol. 1990 Nov;101(3):710-4. doi: 10.1111/j.1476-5381.1990.tb14145.x.
2
Barbiturates bind to an allosteric regulatory site on nicotinic acetylcholine receptor-rich membranes.巴比妥类药物与富含烟碱型乙酰胆碱受体的膜上的变构调节位点结合。
Mol Pharmacol. 1987 Jul;32(1):119-26.
3
Modulation of the GABAA receptor by depressant barbiturates and pregnane steroids.镇静性巴比妥类药物和孕烷类固醇对GABAA受体的调节作用。
Br J Pharmacol. 1988 Aug;94(4):1257-69. doi: 10.1111/j.1476-5381.1988.tb11646.x.
4
Interaction of barbiturate analogs with the Torpedo californica nicotinic acetylcholine receptor ion channel.巴比妥酸盐类似物与加州电鳐烟碱型乙酰胆碱受体离子通道的相互作用。
Mol Pharmacol. 2001 Sep;60(3):497-506.
5
Barbiturate action is dependent on the conformational state of the acetylcholine receptor.巴比妥类药物的作用取决于乙酰胆碱受体的构象状态。
Anesthesiology. 1993 Nov;79(5):1033-41. doi: 10.1097/00000542-199311000-00022.
6
Modulation of phencyclidine-sensitive ethidium binding to the Torpedo acetylcholine receptor: interaction of noncompetitive inhibitors with carbamylcholine and cobra alpha-toxin.苯环利定敏感的溴化乙锭与电鳐乙酰胆碱受体结合的调节:非竞争性抑制剂与氨甲酰胆碱和眼镜蛇α-毒素的相互作用。
Mol Pharmacol. 1992 Feb;41(2):331-6.
7
Actions of pentobarbital enantiomers on nicotinic cholinergic receptors.戊巴比妥对映体对烟碱型胆碱能受体的作用。
Mol Pharmacol. 1989 Dec;36(6):874-80.
8
The influence of barbiturate drugs on tetraethylammonium induced contractures of the chick biventer cervicis muscle in vitro.巴比妥类药物对体外培养的雏鸡颈二腹肌四乙铵诱导挛缩的影响。
Gen Pharmacol. 1984;15(5):411-4. doi: 10.1016/0306-3623(84)90040-5.
9
Phenobarbitone binding sites in rat brain synaptosomal membranes.大鼠脑突触体膜中的苯巴比妥结合位点。
Neurosci Lett. 1981 Jul 17;24(3):301-6. doi: 10.1016/0304-3940(81)90175-0.
10
Properties of Torpedo electric organ muscarinic receptors.电鳐电器官毒蕈碱受体的特性
J Physiol (Paris). 1982;78(4):379-84.

引用本文的文献

1
Identifying barbiturate binding sites in a nicotinic acetylcholine receptor with [3H]allyl m-trifluoromethyldiazirine mephobarbital, a photoreactive barbiturate.用 [3H]丙烯基 m-三氟甲基二氮杂环丁酮美散痛(一种光反应性巴比妥酸盐)鉴定烟碱型乙酰胆碱受体中的巴比妥酸盐结合位点。
Mol Pharmacol. 2014 May;85(5):735-46. doi: 10.1124/mol.113.090985. Epub 2014 Feb 21.
2
Specificity of intersubunit general anesthetic-binding sites in the transmembrane domain of the human α1β3γ2 γ-aminobutyric acid type A (GABAA) receptor.人α1β3γ2 γ-氨基丁酸 A 型(GABAA)受体跨膜域中亚基间通用麻醉剂结合位点的特异性。
J Biol Chem. 2013 Jul 5;288(27):19343-57. doi: 10.1074/jbc.M113.479725. Epub 2013 May 15.
3
Mechanisms of barbiturate inhibition of acetylcholine receptor channels.巴比妥类药物对乙酰胆碱受体通道的抑制机制。
J Gen Physiol. 1997 Mar;109(3):401-14. doi: 10.1085/jgp.109.3.401.
4
Inhibition of the nicotinic acetylcholine receptor by barbiturates and by procaine: do they act at different sites?巴比妥类药物和普鲁卡因对烟碱型乙酰胆碱受体的抑制作用:它们作用于不同位点吗?
Cell Mol Neurobiol. 1993 Apr;13(2):159-72. doi: 10.1007/BF00735372.
5
Cholinergic mechanisms in physical dependence on barbiturates, ethanol and benzodiazepines.巴比妥类、乙醇和苯二氮䓬类药物身体依赖中的胆碱能机制。
J Neural Transm Gen Sect. 1992;88(3):199-221. doi: 10.1007/BF01244733.

本文引用的文献

1
Quantitative studies of the demethylation of N-methyl barbital (metharbital, gemonil).N-甲基巴比妥(美索比妥,盖眠宁)去甲基化的定量研究
J Pharmacol Exp Ther. 1953 Aug;108(4):474-80.
2
Kinetics of binding of [3H]acetylcholine to Torpedo postsynaptic membranes: association and dissociation rate constants by rapid mixing and ultrafiltration.[3H]乙酰胆碱与电鳐突触后膜结合的动力学:通过快速混合和超滤测定结合和解离速率常数
Biochemistry. 1980 Nov 11;19(23):5353-8. doi: 10.1021/bi00564a032.
3
Multiple sites of action for noncompetitive blockers on acetylcholine receptor rich membrane fragments from torpedo marmorata.非竞争性阻滞剂对电鳐富含乙酰胆碱受体的膜片段的多个作用位点。
Biochemistry. 1983 Jun 21;22(13):3112-27. doi: 10.1021/bi00282a014.
4
Interactions of barbiturates of various pharmacological categories with benzodiazepine receptors.不同药理类别的巴比妥类药物与苯二氮䓬受体的相互作用。
Mol Pharmacol. 1982 Mar;21(2):320-8.
5
Drug interactions at the GABA receptor-ionophore complex.γ-氨基丁酸(GABA)受体-离子载体复合物处的药物相互作用。
Annu Rev Pharmacol Toxicol. 1982;22:245-77. doi: 10.1146/annurev.pa.22.040182.001333.
6
Interaction of barbiturates with benzodiazepine receptors in the central nervous system.巴比妥类药物与中枢神经系统中苯二氮䓬受体的相互作用。
Brain Res. 1982 Feb 4;233(1):143-56. doi: 10.1016/0006-8993(82)90936-2.
7
Mechanism of action of barbiturates.巴比妥类药物的作用机制。
Annu Rev Pharmacol Toxicol. 1981;21:83-111. doi: 10.1146/annurev.pa.21.040181.000503.
8
Pharmacology of barbiturates: electrophysiological and neurochemical studies.巴比妥类药物的药理学:电生理学和神经化学研究
Int Rev Neurobiol. 1983;24:15-49. doi: 10.1016/s0074-7742(08)60219-6.
9
Barbiturates: their in vivo effects and potential biochemical mechanisms.巴比妥类药物:它们的体内效应及潜在生化机制。
Prog Neurobiol. 1982;18(4):275-319. doi: 10.1016/0301-0082(82)90013-2.
10
Barbiturates allosterically inhibit GABA antagonist and benzodiazepine inverse agonist binding.巴比妥类药物变构抑制γ-氨基丁酸(GABA)拮抗剂和苯二氮䓬类反向激动剂的结合。
Eur J Pharmacol. 1984 Jul 13;102(2):205-12. doi: 10.1016/0014-2999(84)90252-8.

巴比妥酸盐与电鳐乙酰胆碱受体结合的相对效价。

Relative potencies for barbiturate binding to the Torpedo acetylcholine receptor.

作者信息

Dodson B A, Urh R R, Miller K W

机构信息

Department of Anaesthesia, Massachusetts General Hospital, Harvard Medical School, Boston 02114.

出版信息

Br J Pharmacol. 1990 Nov;101(3):710-4. doi: 10.1111/j.1476-5381.1990.tb14145.x.

DOI:10.1111/j.1476-5381.1990.tb14145.x
PMID:1963806
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1917748/
Abstract
  1. The structural requirements of an allosteric barbiturate binding site on acetylcholine receptor-rich membranes isolated from Torpedo electroplaques have been characterized by the ability of fourteen barbiturates to displace [14C]-amobarbitone binding. 2. The barbiturates could be grouped into two classes with ten barbiturates producing a strong inhibition of [14C]-amobarbitone binding (class one) and with four exerting minimal effects (class two). 3. Eight of the ten class one barbiturates displaced essentially all of the [14C]-amobarbitone from its binding site, while, at their respective aqueous solubility limits, two of these barbiturates (thiopentone and dimethylbutylbarbitone (DMBB) inhibited [14C]-amobarbitone binding by nearly 80%. The apparent inhibition constants (KI) for the class one barbiturates ranged from 13 microM for amobarbitone to 2.8 mM for barbitone with the other eight agents lying in the range 100-600 microM, and having the rank order pentobarbitone approximately secobarbitone greater than thiopentone greater than DMBB greater than butabarbitone approximately phenobarbitone greater than aprobarbitone greater than allylbarbitone. 4. By contrast, the class two barbiturates had minimal effects even at close to saturating concentrations. [14C]-amobarbitone binding was reduced slightly (less than 30%) by hexobarbitone, mephobarbitone and methohexitone and was enhanced slightly (less than 20%) by metharbitone. 5. All of the class two, but none of the class one barbiturates, were N-methylated.
摘要
  1. 从电鳐电器官分离得到的富含乙酰胆碱受体的膜上变构巴比妥结合位点的结构要求,已通过14种巴比妥酸盐取代[14C] -异戊巴比妥结合的能力进行了表征。2. 这些巴比妥酸盐可分为两类,其中10种巴比妥酸盐对[14C] -异戊巴比妥结合产生强烈抑制作用(一类),4种作用极小(二类)。3. 10种一类巴比妥酸盐中的8种基本上将所有[14C] -异戊巴比妥从其结合位点上取代,而在各自的水溶性极限下,其中两种巴比妥酸盐(硫喷妥钠和二甲基丁基巴比妥(DMBB))抑制[14C] -异戊巴比妥结合近80%。一类巴比妥酸盐的表观抑制常数(KI)范围从异戊巴比妥的13微摩尔到巴比妥的2.8毫摩尔,其他8种试剂在100 - 600微摩尔范围内,其顺序为戊巴比妥约等于司可巴比妥大于硫喷妥钠大于DMBB大于布他比妥约等于苯巴比妥大于阿普比妥大于烯丙基巴比妥。4. 相比之下,二类巴比妥酸盐即使在接近饱和浓度时也作用极小。[14C] -异戊巴比妥结合被己巴比妥、美索比妥和甲己炔巴比妥轻微降低(小于30%),并被甲基巴比妥轻微增强(小于20%)。5. 所有二类巴比妥酸盐都是N -甲基化的,但一类巴比妥酸盐都不是。